Drug Pipeline

BMS-986253 Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
1
Recruiting
2
Top Sponsors
Active Studies by Phase
Phase 2
3
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT03026140 Neoadjuvant Immune Checkpoint Inhibition and Novel IO Combinations in Early-stage Colon… Colon Carcinoma Recruiting
NCT04848116 Neoadjuvant Targeting of Myeloid Cell Populations in Combination With Nivolumab in Head &… Head and Neck Squamous Cell Carcinoma Active, Not Recruiting
NCT02451982 Platform Study of Neoadjuvant and Adjuvant Immunotherapy for Patients With Resectable… Pancreatic Cancer Active, Not Recruiting
Sponsors Running BMS-986253 Trials
Disease Areas
Get alerts when BMS-986253 trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free